Jun 13, 2022 / 09:40PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Right. Thanks, everybody, for joining us. My name is Matt Sykes. I'm the life science tools and diagnostics analyst at Goldman Sachs. And today, we have the pleasure of hosting Veracyte, CEO, Marc Stapley; and Chief Financial Officer, Rebecca Chambers. Thank you. Marc and Rebecca, for being here today. Really appreciate it.
Marc A. Stapley - Veracyte, Inc. - CEO & Director
Thanks for having us.
Rebecca Chambers - Veracyte, Inc. - Executive VP & CFO
Thank you for having us.
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Maybe Marc, Rebecca, maybe will kind of set the -- help you set the stage for us, maybe some introductory comments about the year so far? And then maybe, Marc, this is probably about your 1-year anniversary, so maybe some highlights as you reflect back on your first year at Veracyte.
Marc A. Stapley
Veracyte Inc at Goldman Sachs Global Healthcare Conference Transcript
Feb 29, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers